Subscribe to Newsletter

Trends & Forecasts

Discovery & Development Drug Discovery

Looking to Next-Generation Sequencing and Multi Omics Technologies

| 2 min read

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 2

| Stephanie Vine | 9 min read

We take a deep dive into key industry trends off the back of Clarivate’s Drugs to Watch 2025 report

Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 2

| 7 min read

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 1

| Stephanie Vine | 8 min read

We speak with Clarivate about their report listing eleven key drugs to watch in 2025.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 1

| 10 min read

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

Business & Regulation Standards & Regulation

AMF’s 2026 AMR Strategy, Revealed

| Rob Coker | 3 min read

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Discovery & Development Clinical Trials

A Shared Vision for Global Health

| 2 min read

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Business & Regulation Trends & Forecasts

Our Videos: The Greatest Hits

| 1 min read

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Manufacture Bioprocessing - Upstream & Downstream

The Era of Antibody 2.0

| 2 min read

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register